tradingkey.logo
tradingkey.logo
Search

iRhythm Technologies Inc

IRTC
Add to Watchlist
114.000USD
-0.160-0.14%
Close 05/15, 16:00ETQuotes delayed by 15 min
3.75BMarket Cap
LossP/E TTM

iRhythm Technologies Inc

114.000
-0.160-0.14%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-0.14%

5 Days

-5.52%

1 Month

-7.02%

6 Months

-33.26%

Year to Date

-35.75%

1 Year

-19.15%

Key Insights

iRhythm Technologies Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 19 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 184.85.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

iRhythm Technologies Inc's Score

Industry at a Glance

Industry Ranking
19 / 206
Overall Ranking
84 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

iRhythm Technologies Inc Highlights

StrengthsRisks
iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 51.65% year-on-year.
Undervalued
The company’s latest PE is -134.30, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 35.19M shares, decreasing 7.70% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 15.66K shares of this stock.

Analyst Rating

Based on 15 analysts
Buy
Current Rating
184.846
Target Price
+61.21%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

iRhythm Technologies Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

iRhythm Technologies Inc Info

iRhythm Technologies, Inc. is a digital health care company, which creates solutions that detect, predict, and prevent disease. The Company designs, develops, and commercializes device-based technology to provide ambulatory cardiac monitoring services. It offers three Zio System options: the Zio Monitor System, the Zio XT System, and the Zio AT System. It offers its Zio ambulatory cardiac monitoring services, including long-term continuous monitoring, short-term continuous monitoring, and mobile cardiac telemetry (MCT) monitoring services (Zio Services), using its Zio Systems. The Zio Monitor System is a prescription-only, remote ECG monitoring system that consists of a patch ECG monitor (the Zio Monitor patch) that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software (ZEUS) System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period.
Ticker SymbolIRTC
CompanyiRhythm Technologies Inc
CEOBlackford (Quentin S)
Websitehttps://www.irhythmtech.com/
KeyAI